Predictors of remission after electroconvulsive therapy in unipolar major depression

Journal of Clinical Psychiatry

Volumn 66, Issue 8, 2005, Pages 1043-1049

  Dombrovski, Alexandre Y ^a   Mulsant, Benoit H ^a,b,d   Haskett, Roger F ^a   Prudic, Joan ^c   Begley, Amy E ^a   Sackeim, Harold A ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d WPIC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; FLUOXETINE; IMIPRAMINE; LORAZEPAM; PAROXETINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; COMORBIDITY; DISEASE SEVERITY; DRUG RESISTANCE; DYSTHYMIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; ONSET AGE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 23944522012     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0813     Document Type: Article

References (63)

1. Hobson RF. Prognostic factors in electric convulsive therapy. J Neurochem 1953;16:275-281
2. Hamilton M, White JM. Factors related to the outcome of depression treated with ECT. J Ment Sci 1960;106:1031-1041
3. Rose JT. Reactive and endogenous depressions: response to ECT. Br J Psychiatry 1963;109:213-217
4. Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 1965;111:659-674
5. Fink M. Predictors of outcome in convulsive therapy. Psychopharmacol Bull 1982;18:50-57
6. Bush G, Fink M, Petrides G, et al. Catalonia, 2: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143
7. Girish K, Gill NS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry 2003;45:21-25
8. Coryell W, Zimmerman M. Outcome following ECT for primary unipolar depression: a test of newly proposed response predictors. Am J Psychiatry 1984;141:862-867
9. Zimmerman M, Coryell W, Pfohl B. The treatment validity of DSM-III melancholic subtyping. Psychiatry Res 1985;16:37-43
10. Hamilton M. Electroconvulsive therapy: indications and contraindications. Ann N Y Acad Sci 1986;462:5-11
11. Sackeim HA, Rush AJ. Melancholia and response to ECT [letter]. Am J Psychiatry 1995;152:1242-1243
12. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996;153:985-992
13. Tew JD Jr, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999;156:1865-1870
14. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmaco-therapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-1307
15. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104
16. Oquendo MA, Baca-Garcia E, Kartachov A, et al. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry 2003;64:825-833
17. Mulsant BH, Haskett RF, Prudic J, et al. Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry 1997;154:559-561
18. Nierenberg AA. Predictors of response to antidepressants general principles and clinical implications. Psychiatr Clin North Am 2003;26:345-352, viii
19. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003;53:649-659
20. Oslin DW, Datto CJ, Kallan MJ, et al. Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002;50:823-828
21. Sonawalla SB, Papakostas GI, Petersen TJ, et al. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder. Psychosomatics 2002;43:310-316
22. Miller MD, Lenze EJ, Dew MA, et al. Effect of cerebrovascular risk factors on depression treatment outcome in later life. Am J Geriatr Psychiatry 2002;10:592-598
23. Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430-436
24. Mulsant BH, Sweet RA, Rosen J, et al. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 2001;62:597-604
25. Coryell W, Endicott J, Keller M. Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry 1990;147:1627-1633
26. Mynors-Wallis L, Gath D. Predictors of treatment outcome for major depression in primary care. Psychol Med 1997;27:731-736
27. Fava M, Uebelacker LA, Alpert JE, et al. Major depressive subtypes and treatment response. Biol Psychiatry 1997;42:568-576
28. Stewart JW, McGrath PJ, Quitkin FM, et al. Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression: differential response to phenelzine, imipramine, and placebo. Arch Gen Psychiatry 1989;46:1080-1087
29. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 1998;280:1665-1672
30. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electro-convulsive therapy. N Engl J Med 1993;328:839-846
31. Feske U, Mulsant BH, Pilkonis PA, et al. Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry 2004;161:2073-2080
32. Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am 1991;14:905-923
33. Shah PJ, Ebmeier KP, Glabus MF, et al. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br J Psychiatry 1998;172:527-532
34. Shah PJ, Glabus MF, Goodwin GM, et al. Chronic, treatment-resistant depression and right fronto-striatal atrophy. Br J Psychiatry 2002;180:434-440
35. Sheline YI, Mittler BL, Mintun MA. The hippocampus and depression. Eur Psychiatry 2002;17(suppl 3):300-305
36. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:1085-1098
37. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998;95:13290-13295
38. D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord 2002;4:183-194
39. Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986
40. Eaton WW, Anthony JC, Gallo JJ, et al. Natural history of diagnostic interview schedule/DSM-IV major depression: the Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry 1997;54:993-999
41. Spijker J, de Graaf R, Bijl RV, et al. Duration of major depressive episodes in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002;181:208-213
42. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder [Revision]. Am J Psychiatry 2002;157(suppl 1):1-45
43. Thase ME. Treatment of severe depression. J Clin Psychiatry 2000;61(suppl 1):17-25
44. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361:799-808
45. Avery D, Lubrano A. Depression treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 1979;136:559-562
46. Thiery M. Clinical trial of the treatment of depressive illness: report to the Medical Research Council by its clinical psychiatry committee. Br Med J 1965;5439:881-886
47. Mandel MR, Welch CA, Mieske M, et al. Prediction of response to ECT in tricyclic-intolerant and tricyclic-resistant depressed patients. McLean Hospital Journal 1977;2:203-209,
48. cited in Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am 1991;14:905-923
49. Paul SM, Extein I, Calil HM, et al. Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health. Am J Psychiatry 1981;138:486-489
50. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287-296
51. Lam RW, Bartley S, Yatham LN, et al. Clinical predictors of short-term outcome in electroconvulsive therapy. Can J Psychiatry 1999;44:158-163
52. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-434
53. Pluijms EM, Birkenhager TK, Huijbrechts IP, et al. Influence of resistance to antidepressant pharmacotherapy on short-term response to electroconvulsive therapy. J Affect Disord 2002;69:93-99
54. van den Broek WW, de Lely A, Mulder PGH, et al. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol 2004;24:400-403
55. Kukopulos A, Reginaldi D, Tondo L, et al. Spontaneous length of depression and response to ECT. Psychol Med 1977;7:625-629
56. Dunn CG, Quinlan D. Indicators of ECT response and non-response in the treatment of depression. J Clin Psychiatry 1978;39:620-622
57. Magni G, Fisman M, Helmes E. Clinical correlates of ECT-resistant depression in the elderly. J Clin Psychiatry 1988;49:405-407
58. Kindler S, Shapira B, Hadjez J, et al. Factors influencing response to bilateral electroconvulsive therapy in major depression. Convuls Ther 1991;7:245-254
59. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, Third Edition, Updated. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1984
60. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS), Third Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1977
61. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
62. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
63. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-248